Avalo Therapeutics logo

Avalo Therapeutics share price today

(AVTX)

Avalo Therapeutics share price is $8.81 & ₹750.59 as on 25 Dec 2024, 2.30 'hrs' IST

$8.81

-0.28

(-3.08%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Avalo Therapeutics share price in Dollar and Rupees. Guide to invest in Avalo Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Avalo Therapeutics. Get details on the Indian mutual funds that are investing in Avalo Therapeutics. Get Analyst recommendations and forecasts along with all the Avalo Therapeutics's financials.

Avalo Therapeutics share price movements

  • Today's Low: $8.67
    Today's High: $9.41

    Day's Volatility :7.86%

  • 52 Weeks Low: $3.95
    52 Weeks High: $34.46

    52 Weeks Volatility :88.54%

Avalo Therapeutics Returns

PeriodAvalo Therapeutics IncIndex (Russel 2000)
3 Months
-5.78%
0.0%
6 Months
-33.26%
0.0%
1 Year
-29.41%
0.0%
3 Years
-99.83%
-21.1%

Avalo Therapeutics Key Statistics

in dollars & INR

Previous Close
$9.09
Open
$9.13
Today's High
$9.41
Today's Low
$8.6701
Market Capitalization
$92.2M
Today's Volume
$38.6K
52 Week High
$34.46
52 Week Low
$3.9501
Revenue TTM
$820.0K
EBITDA
$-31.2M
Earnings Per Share (EPS)
$94.42
PE Ratio
0.09
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-42.52%

How to invest in Avalo Therapeutics from India?

It is very easy for Indian residents to invest directly in Avalo Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Avalo Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Avalo Therapeutics or AVTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Avalo Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Avalo Therapeutics shares which would translate to 0.097 fractional shares of Avalo Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Avalo Therapeutics, in just a few clicks!

Returns in Avalo Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Avalo Therapeutics investment value today

Current value as on today

₹72,832

Returns

₹27,168

(-27.17%)

Returns from Avalo Therapeutics Stock

₹29,407 (-29.41%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Avalo Therapeutics

-25%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Avalo Therapeutics on INDmoney from India has reduced in the last 30 days as on Dec 26, 2024. -25% less investors are searching Avalo Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Avalo Therapeutics

  • Ikarian Capital, LLC

    9.27%

  • Orbimed Advisors, LLC

    9.24%

  • Deep Track Capital, LP

    9.24%

  • Bvf Inc

    9.24%

  • RA Capital Management, LLC

    9.24%

  • Logos Global Management LP

    5.15%

Analyst Recommendation on Avalo Therapeutics

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Avalo Therapeutics(by analysts ranked 0 to 5 stars)

Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
3
3
3
Sell
3
3
3

Analyst Forecast on Avalo Therapeutics

What analysts predicted

Upside of 325.65%

Current:

$8.81

Target:

$37.50

Insights on Avalo Therapeutics

  • Price Movement

    In the last 3 years, AVTX stock has moved down by -99.8%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 571.0K → 249.0K (in $), with an average decrease of 56.4% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 98.46M → 23.03M (in $), with an average decrease of 76.6% per quarter
  • AVTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 56.6%
  • AVTX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 125.0%
  • Price to Sales

    ForAVTX every $1 of sales, investors are willing to pay $22.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Avalo Therapeutics Technicals Summary

Sell

Neutral

Buy

Avalo Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Avalo Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Avalo Therapeutics Inc
-11.81%
-33.26%
-29.41%
-99.83%
-99.89%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-3.72%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Avalo Therapeutics Inc
0.09
0.09
NA
0.0
-0.43
-0.31
NA
2.18
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Avalo Therapeutics Inc
Sell
$92.2M
-99.89%
0.09
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Avalo Therapeutics

cerecor inc. is a biopharmaceutical company focused on the discovery, development and commercialization of prescription pharmaceuticals whose primary activity is in the human brain. we are a delaware corporation, organized in april 2011 in partnership with various laboratories and research institutes at johns hopkins medical institute ("jhmi"). cerecor is focused on translational medicine – the accelerated transfer of technology from the academic laboratory to early human trials, with the goal of rapid commercialization. we acquire rights to early stage therapeutic technologies ("assets") from universities, finance and manage the development of these assets into drug candidates (to first major milestone or value inflection point) and then either commercialize or outlicense the asset.
Organization
Avalo Therapeutics
Employees
19
CEO
Dr. Garry A. Neil M.D.
Industry
Miscellaneous

Management People of Avalo Therapeutics

NameTitle
Dr. Garry A. Neil M.D.
Chairman of the Board, President & CEO
Mr. Christopher Ryan Sullivan CPA
CFO & Head of Investor relations
Dr. Solomon H. Snyder M.D.
Founder and Chairman of Scientific Advisory Board
Dr. Barbara S. Slusher Ph.D.
Founder and Member of Scientific Advisory Board
Mr. Paul C. Varki J.D., M.P.H
Chief Legal Officer
Dr. Lisa Hegg Ph.D.
Senior Vice President of Program Management, Corporate Infrastructure & Clinical Operations
Ms. Colleen Matkowski
Senior Vice President of Global Regulatory Affairs & Quality Assurance
Dr. Dino C. Miano Ph.D.
Senior Vice President of CMC & Technical Operations
Dr. Mittie Doyle FACR, M.D.
Chief Medical Officer

Important FAQs about investing in Avalo Therapeutics from India :

What is Avalo Therapeutics share price today?

Avalo Therapeutics share price today stands at $8.81, Open: $9.13 ; Previous Close: $9.09 ; High: $9.41 ; Low: $8.67 ; 52 Week High: $34.46 ; 52 Week Low: $3.95. The stock opens at $9.13, after a previous close of $9.09. The stock reached a daily high of $9.41 and a low of $8.67, with a 52-week high of $34.46 and a 52-week low of $3.95.

Can Indians buy Avalo Therapeutics shares?

Yes, Indians can invest in the Avalo Therapeutics (AVTX) from India.

With INDmoney, you can buy Avalo Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Avalo Therapeutics at zero transaction cost.

How can I buy Avalo Therapeutics shares from India?

It is very easy to buy Avalo Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Avalo Therapeutics be purchased?

Yes, you can buy fractional shares of Avalo Therapeutics with INDmoney app.

What are the documents required to start investing in Avalo Therapeutics stocks?

To start investing in Avalo Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Avalo Therapeutics

Today’s highest price of Avalo Therapeutics (AVTX) is $9.41.

Today’s lowest price of Avalo Therapeutics (AVTX) is $8.67.

What is today's market capitalisation of Avalo Therapeutics

Today's market capitalisation of Avalo Therapeutics AVTX is 92.2M

What is the 52 Week High and Low Range of Avalo Therapeutics

  • 52 Week High

    $34.46

  • 52 Week Low

    $3.95

What are the historical returns of Avalo Therapeutics?

  • 1 Month Returns

    -11.81%

  • 3 Months Returns

    -33.26%

  • 1 Year Returns

    -29.41%

  • 5 Years Returns

    -99.89%

Who is the Chief Executive Officer (CEO) of Avalo Therapeutics

Dr. Garry A. Neil M.D. is the current Chief Executive Officer (CEO) of Avalo Therapeutics.